Medicine and Dentistry
Abciximab
6%
Acute Cardiac Care
25%
Acute Coronary Syndrome
50%
Cardiology
100%
Cardiovascular System
25%
Chronic Total Occlusion
25%
Congestive Heart Failure
29%
Contrast Medium
25%
Coronary Occlusion
16%
Dose Area Product
8%
Drug Therapy
6%
Everolimus
25%
Heart Surgery
27%
Hospital Mortality
10%
Infarction
9%
Intention-to-Treat Analysis
8%
New York Heart Association Class
25%
Optical Coherence Tomography
7%
Percutaneous Aortic Valve Replacement
25%
Percutaneous Coronary Intervention
50%
Primary Percutaneous Coronary Intervention
35%
Radiation Exposure
25%
Recanalization
8%
Reperfusion Therapy
31%
Revascularization
8%
ST Segment Elevation Myocardial Infarction
100%
Valvular Heart Disease
12%
Pharmacology, Toxicology and Pharmaceutical Science
Abciximab
7%
Acute Coronary Syndrome
25%
Angiotensin Receptor Antagonist
5%
Anterior Myocardial Infarction
7%
Beta Adrenergic Receptor Blocking Agent
5%
Congestive Heart Failure
30%
Coronary Artery Occlusion
16%
Dipeptidyl Carboxypeptidase Inhibitor
5%
Hospital Mortality
10%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
5%
Infarction
9%
Major Adverse Cardiac Event
25%
Pharmacotherapy
5%
Prospective Cohort Study
5%
ST Segment Elevation Myocardial Infarction
75%
